You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial

Citation Tools

Article menu
Download PDFPDF
Abstracts accepted for publication
Rheumatoid arthritis - anti-TNF therapy
AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Westhovens R, Bingham CO, Weinblatt M, et al
AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial
Annals of the Rheumatic Diseases 2013;72:A873.